June 28, 2024
Scientific symposium highlights latest developments in pancreatic cancer research
UNC Lineberger’s 47th annual scientific symposium featured 17 presentations from faculty at UNC Lineberger and institutions across the United States.
June 28, 2024
UNC Lineberger’s 47th annual scientific symposium featured 17 presentations from faculty at UNC Lineberger and institutions across the United States.
June 7, 2024
The American Society of Clinical Oncology and Conquer Cancer recognized UNC Lineberger faculty and trainees at ASCO’s annual meeting.
June 4, 2024
May 28, 2024
UNC and UNC Lineberger researchers and trainees will be presenting talks and participating in scientific and educational panels and discussions on the latest cancer research at the ASCO Annual Meeting.
May 17, 2024
In a commentary in JAMA Oncology, José Gaston Guillem, MD, MPH, MBA, FACS, FASCRS, cautions against the rush to extend the treatment approach to patients whose cancer has nearly, but not completely, responded to chemotherapy and radiation therapy.
April 30, 2024
For Siddharth Sheth, DO, MPH, he knew UNC was the place for him when he pursued his first faculty position in medicine. However, it wasn’t just UNC that shaped his medical career. When Sheth’s mom was diagnosed with cancer and later relapsed, he knew oncology was the right path for him.
April 9, 2024
Lisa Carey, MD, ScM, FASCO, was honored for her distinguished service over the years leading outstanding clinical and translational research and her work in eradicating health disparities.
April 9, 2024
UNC Health social worker Rose Wilson, MSW, and UNC Health oncologist Jared Weiss, MD, discuss the physical and emotional considerations of long-term cancer care.
March 26, 2024
Researchers and trainees from UNC and UNC Lineberger at will present more than 30 talks and participate in scientific and educational panels and discussions on the latest cancer research.
March 4, 2024
The grant will support the first metastatic pancreatic cancer trial in the country to evaluate whether selecting treatment by tumor subtype will help patients match to more effective first-line therapies.